catechin has been researched along with Amyotrophic Lateral Sclerosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rajasekaran, R; Srinivasan, E | 1 |
| Hwang, MS; Kim, HT; Kim, HY; Kim, J; Kim, MH; Kim, OH; Kim, SH; Koh, SH; Lee, KW; Lee, KY; Lee, SM; Lee, YJ; Song, C; Yang, KW | 1 |
| Chen, S; Le, W; Li, L; Li, X; Luo, G; Xu, Z | 1 |
3 other study(ies) available for catechin and Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Probing the inhibitory activity of epigallocatechin-gallate on toxic aggregates of mutant (L84F) SOD1 protein through geometry based sampling and steered molecular dynamics.
Topics: Amyotrophic Lateral Sclerosis; Catalytic Domain; Catechin; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Molecular Dynamics Simulation; Mutation, Missense; Protein Aggregates; Protein Binding; Protein Conformation, alpha-Helical; Superoxide Dismutase-1; Thermodynamics | 2017 |
The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice.
Topics: Amyotrophic Lateral Sclerosis; Animals; Blotting, Western; Caspase 3; Caspases; Catechin; Disease Models, Animal; Disease Progression; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Mice; Mice, Transgenic; Motor Activity; Mutation; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1 | 2006 |
Neuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Blotting, Western; Caspase 3; Catechin; Disease Models, Animal; Enzyme Activation; Female; Immunohistochemistry; Male; Mice; Mice, Transgenic; Microglia; Motor Neurons; Neuroprotective Agents; NF-kappa B | 2006 |